Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Korístek

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Vnitrni Lekarstvi|September 11, 2008
[Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia]Z Korístek, J Mayer
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Bone marrow processing for transplantation using the COBE spectra cell separatorZ Korístek, J Mayer
Vnitrni Lekarstvi|September 11, 2008
[Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia]Z Korístek, P Zák
Vnitrni Lekarstvi|September 11, 2008
[Relapse in acute promyelocytic leukemia and the role of hematopoietic stem cell transplantation in the treatment of APL]P Zák, Z Korístek
Vnitrni Lekarstvi|September 11, 2008
[Brief case reports illustrate various initial courses in acute promyelocytic leukemia]Z Korístek, J Schwarz, P Zák
Bone Marrow Transplantation|October 2, 2003
Mathematical model of peripheral blood stem cell harvest kineticsJ Mayer, Z Pospísil, Z Korístek
Bone Marrow Transplantation|February 13, 2002
Technique for PBSC harvesting in children of weight under 10 kgZ Korístek, J Sterba, D Havranová, et al.
Vnitrni Lekarstvi|April 9, 2008
[The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]Z Adam, V Scudla, M Krejcí, et al.
Vnitrni Lekarstvi|August 19, 2007
[Improvement in the results of treatment of selected blood diseases and changes in the costs of such treatment. Issues for economists and other experts]Z Adam, J Vorlícek, Z Korístek, et al.
Casopis Lekaru Ceskych|October 1, 2003
[Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation]M Klabusay, V Suková, Z Korístek, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Vnitrni Lekarstvi|September 11, 2008
[Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia]Z Korístek, J Mayer
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Bone marrow processing for transplantation using the COBE spectra cell separatorZ Korístek, J Mayer
Vnitrni Lekarstvi|September 11, 2008
[Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia]Z Korístek, P Zák
Vnitrni Lekarstvi|September 11, 2008
[Relapse in acute promyelocytic leukemia and the role of hematopoietic stem cell transplantation in the treatment of APL]P Zák, Z Korístek
Vnitrni Lekarstvi|September 11, 2008
[Brief case reports illustrate various initial courses in acute promyelocytic leukemia]Z Korístek, J Schwarz, P Zák
Bone Marrow Transplantation|October 2, 2003
Mathematical model of peripheral blood stem cell harvest kineticsJ Mayer, Z Pospísil, Z Korístek
Bone Marrow Transplantation|February 13, 2002
Technique for PBSC harvesting in children of weight under 10 kgZ Korístek, J Sterba, D Havranová, et al.
Vnitrni Lekarstvi|April 9, 2008
[The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]Z Adam, V Scudla, M Krejcí, et al.
Vnitrni Lekarstvi|August 19, 2007
[Improvement in the results of treatment of selected blood diseases and changes in the costs of such treatment. Issues for economists and other experts]Z Adam, J Vorlícek, Z Korístek, et al.
Casopis Lekaru Ceskych|October 1, 2003
[Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation]M Klabusay, V Suková, Z Korístek, et al.
Pageof 4